Normal DVT resolution, primarily relying on macrophages, involves CXCR2-mediated neovascularization, collagen conversion, and fibrinolysis using a CXCR2−/− mouse DVT model (Henke et al., 2004). The gene discussed is CXCR2; the disease is deep vein thrombosis.